Cabot Co. (NYSE:CBT – Get Free Report) CAO Lisa M. Dumont sold 865 shares of Cabot stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $111.74, for a total value of $96,655.10. Following the completion of the sale, the chief accounting officer now owns 9,742 shares in the company, valued at approximately $1,088,571.08. The trade was a 8.15 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Cabot Trading Down 1.6 %
NYSE:CBT traded down $1.75 during trading hours on Thursday, reaching $109.20. 340,441 shares of the stock were exchanged, compared to its average volume of 344,444. The company has a quick ratio of 1.36, a current ratio of 2.08 and a debt-to-equity ratio of 0.68. The business has a 50-day moving average of $109.78 and a two-hundred day moving average of $101.98. Cabot Co. has a twelve month low of $70.63 and a twelve month high of $117.46. The company has a market capitalization of $5.99 billion, a price-to-earnings ratio of 16.20, a PEG ratio of 0.96 and a beta of 1.20.
Cabot (NYSE:CBT – Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $1.80 earnings per share for the quarter, missing analysts’ consensus estimates of $1.81 by ($0.01). Cabot had a return on equity of 26.60% and a net margin of 9.51%. The company had revenue of $1 billion for the quarter, compared to analysts’ expectations of $1.01 billion. During the same period in the prior year, the company posted $1.65 EPS. The firm’s revenue was up 3.7% compared to the same quarter last year. On average, equities analysts predict that Cabot Co. will post 7.7 EPS for the current year.
Cabot Announces Dividend
Hedge Funds Weigh In On Cabot
Large investors have recently bought and sold shares of the business. Eventide Asset Management LLC boosted its stake in Cabot by 19.8% in the third quarter. Eventide Asset Management LLC now owns 122,820 shares of the specialty chemicals company’s stock valued at $13,728,000 after acquiring an additional 20,273 shares in the last quarter. Verition Fund Management LLC boosted its stake in Cabot by 47.1% in the third quarter. Verition Fund Management LLC now owns 6,911 shares of the specialty chemicals company’s stock valued at $772,000 after acquiring an additional 2,212 shares in the last quarter. Captrust Financial Advisors boosted its stake in Cabot by 8.4% in the third quarter. Captrust Financial Advisors now owns 9,090 shares of the specialty chemicals company’s stock valued at $1,016,000 after acquiring an additional 704 shares in the last quarter. Isthmus Partners LLC boosted its stake in Cabot by 12.7% in the third quarter. Isthmus Partners LLC now owns 3,885 shares of the specialty chemicals company’s stock valued at $434,000 after acquiring an additional 439 shares in the last quarter. Finally, Bridgewater Associates LP boosted its stake in Cabot by 11.3% in the third quarter. Bridgewater Associates LP now owns 58,063 shares of the specialty chemicals company’s stock valued at $6,490,000 after acquiring an additional 5,881 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on the company. JPMorgan Chase & Co. cut Cabot from a “neutral” rating to an “underweight” rating and set a $105.00 price objective on the stock. in a report on Monday. UBS Group decreased their target price on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 6th. Finally, Mizuho raised their target price on shares of Cabot from $103.00 to $122.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 5th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, Cabot has a consensus rating of “Hold” and a consensus price target of $105.00.
Get Our Latest Analysis on Cabot
About Cabot
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Stories
- Five stocks we like better than Cabot
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- How to Effectively Use the MarketBeat Ratings Screener
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.